Delivery formulations

IntelGenx, ATAI partner on film-based psychedelics

03-Sep-2020 By Jenni Spinner

The companies will join forces to use IntelGenx’s polymeric film technologies for development of pharmaceutical-grade psychedelic drug treatments.

TFF, Union Therapeutics join on potential COVID-19 treatment

27-Aug-2020 By Jenni Spinner

The companies will partner on developing dry-powder forms of niclosamide as a treatment for the virus, using thin-film freezing technology.

Colorcon invests in AI-centric drug discovery

24-Aug-2020 By Jenni Spinner

The pharmaceutical technology investment fund is partnering with and financing Atomwise, a company that provides AI solutions for drug discovery

Healx collaborates on Angelman syndrome therapies

19-Aug-2020 By Jenni Spinner

The AI-centric drug discovery technology firm is working with a foundation to discover potential treatments for the rare neurogenetic disorder.

Biorasi: precision medicine trials call for specialized approach

19-Aug-2020 By Jenni Spinner

A leader from the speed-focused CRO talks about the specialized needs of precision medicine trials, and how sites and sponsors can succeed on such studies.

People on the Move: August 2020

04-Aug-2020 By Jenni Spinner

This month's spotlight on new hires, promotions and company acquisitions involves Elligo Health Research, PPD, Pfizer, Covance and other industry firms.

Absorption Systems: complex generics offer obstacles, opportunities

21-Jul-2020 By Jenni Spinner

A leader from the CRO shares perspectives on the challenges and rewards associated with the category, and approaches in getting generics to market.

A-Alpha Bio lands Gates Foundation drug development grant

13-Jul-2020 By Jenni Spinner

The $800K grant will fund development of therapeutics for infectious diseases, including respiratory viruses like COVID-19, using machine learning.

G1 Therapeutics: trilaciclib shows benefits for lung cancer patients

14-May-2020 By Jenni Spinner

The company will present data from recent Phase 2 trials of the investigational drug at the upcoming ASCO20 virtual conference on May 29.

3M Drug Delivery Systems relaunches as Kindeva Drug Delivery

04-May-2020 By Jenni Spinner

The launch of the renamed, newly independent company follows its acquisition by Altaris Capital Partners.

Saama launches COVID-19 data collaboration

06-Apr-2020 By Jenni Spinner

The company’s EndPandemic National Data Consortium aims to integrate data from clinical trials to accelerate development of a cure for the virus.

FDA approves migraine drug formulated for fast dispersion

19-Mar-2020 By Vassia Barba

Biohaven’s drug for acute treatment of migraine, manufactured using Catalent’s Zydis technology for orally disintegrating tablets, receives approval from the US FDA.

Formulation method improves bioavailability of poorly soluble molecules

09-Mar-2020 By Vassia Barba

Orion to benefit from Nanoform’s formulation technology, which is able to improve bioavailability and solubility of early-stage compounds.

Merck KGaA partners on 3D-printed tablets manufacture

27-Feb-2020 By Vassia Barba

Merck to produce 3D-printed tablets by tapping into the technology developed by AMCM, making a move towards digitalization.

Taro recalls seizure medicine over suspension problems

24-Feb-2020 By Ben Hargreaves

Taro instigates a voluntary recall of phenytoin oral suspension after two lots are found not to re-suspend when shaken.